Active Systemic Lupus Erythematosus

The acceptable threshold for glucocorticoid use for lupus maintenance therapy should be 5 mg per day prednisone equivalent or less, according to the updated 2023 EULAR recommendations for the management of systemic lupus erythematosus.

Health care professionals around the world are reporting that the COVID-19 pandemic has prevented patients with systemic lupus erythematosus from receiving optimal care, resulting in increased risk for organ damage, according to a survey.

PHILADELPHIA — Phase 2 findings for the tyrosine kinase 2 inhibitor deucravacitinib yielded encouraging results through 48 weeks in patients with systemic lupus erythematosus, according to data presented at ACR Convergence 2022.

Patients with systemic lupus erythematosus demonstrate a relatively high rate of retinopathy at initial diagnosis, and may represent an early manifestation of the disease, according to data published in BMC Rheumatology.

Systemic lupus erythematosus is a risk factor for increased mortality in elderly patients with early breast cancer, according to data published in Arthritis Care & Research.

A complex autoimmune disease like lupus requires multi-pronged, multifactorial approaches for both individual patient management and for broader research and advocacy initiatives. It is difficult to diagnose, treat, and study in clinical trials.